SPMVV, Tirupati. - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/6744/12/12...Eduardo HSB,...

Bibliography

Institute of Pharmaceutical Technology, SPMVV, Tirupati. 157

Abhang RY., 1992. A study to evaluate the effect of a micro (Sukshma) medicine

from a Madhya Rasayana on intelligence of mentally retarded children using

psychological and biochemical parameters. J.Res.Ayur Siddha; 13: 35-47.

Agid Y, Javoy-Agid F, Ruberg M (1987). Biochemistry of neurotransmitters in

Parkinson’s disease: In: Butterworths: 166-230.

Al Ghamdi MS., 2001. The anti-inflammatory, analgesic and antipyretic activity

of Nigella sativa. J. Ethnopharmacol; 76: 45-48.

Albertson DN, Grubbs LE., 2009. Subjective effect of salvia divinorum: LSD-

Ormarijuana-like ?.J. Psychoactive Drugs.41(3) : 213-7.

Albin RL, Young AB, and Penney JB., 1989. The functional anatomy of basal

ganglia disorders. Trends Neurosci; 12: 366-375.

Ale JT, Gabriela EF, Daniel BLA, Cristina T, Guillermo SH., 2000. Biologically

active alkaloids and a free radical scavenger from Prosopis species. J. of

Ethnopharmacology; 71(1-2): 241-246.

Allen ON and Allen EK., 1981. The Leguminosae. The university of Wisconsin

Press. P.812.

Amarnath PL., 2004. Antidiabetic activity of Boerhavia diffusa L: effect on

hepatic key enzyme in experimental diabetes. Journal of Ethnopharmacology. 91:

109-113.

Amato RI, Lipman ZP and Snyder SH., 1986. Selectivity of the Parkinsonian

neurotoxin MPTP: Toxic metabolite MPP+

binds to neuromelanin. Science; 231:

987-989.

Ames BN., 1983. Dietary Carcinogens and anticarcinogen. Science; 221: 1256-

1264.

Bibliography


Anamaria SA, Sabrina RF, Alana FP, Debora CF, Natalia V, Fontenelle CR,

Eduardo HSB, Tales RM, Kyria SN. Benildosousa C., 2009. Vasodilator effect of

Diocleinae lectins form the Canavalia genus. Naunyn-Schmied Arch Pharmacol;

380: 509-521.

Ansell GB and Beeson MF., 1968. A rapid and sensitive procedure for the

combined assay of noradrenaline, dopamine and serotonin in a single brain

sample. Anal. Biochem; 23: 196-206.

Ashok DB, Vadiya., 1997. The status and scope of Indian medicinal plants acting

on CNS. Ind. Journal of Pharmacol; 29(5): 5340-5343.

Auddy B, Ferreiru M, Blasina F, Lafon L, Arredondo F and Dajas F., 2003.

Screening of antioxidant activity of three Indian medicinal plants traditionally

used for the management of neurodegenerative disease. J Ethnopharmacol; 84:

131-138.

Badary OA, Abdel-Niam AB, Abdel-Wahab MH and Hamada FM., 2000. The

influence of thymoquinine on doxorubicin induced hyperlipidemic neuropathy in

rats. Toxicol; 143: 219-26.

Ballard PA., Jetrud JW and Lanston JW., 1985. Permanent human parkinsonism

due to N-methyl-4-phenyl-1,2,3,4 tetrahydropyridine (MPTP): seven cases. Neurology;

35: 949-956.

Banso A, and Adeyemo SO., 2007. Evaluation of antibacterial properties of

tannins isolated from Dichrostachys cinerea. African Journal of Biotechnology; 6

(15): 1785-1787.

Barbiero J, Santiago RM, Lima MM, Ariza D, Morais LH, Andreatini R, Vital

MA., 2011. Acute but not chronic administration of pioglitazone promoted

behavioural and neurochemical protective effect in the MPTP model of

Parkinson’s disease. Behavioral Brain Res; 216 (1): 186-192.

Bibliography


Beal MF, Hyman BT and koroshetz W., 1993. Do defects in mitochondrial

energy metabolism underline the pathology of neurodegenerative disease? Trends

Neurosci; 16: 125-131.

Becker R and Grosjean O-KK., 1980. A compositional study of pods of two

varities of mesquite (Prosopis glandulosa, P. velutina). J. Agric. Food. Chem.

28:22-25.

Ben-Shachar D, Eshel G, Riederer P and Youdim MBH., 1992. Role of iron and

iron chelation in dopaminergic induced neurodegenration: Implication for

parkinson’s disease. Ann. Neurol; 32: 5105-5110.

Bertler A and Rosengren E., 1959. Occurrence and distribution of catecholamines

in brain. Acta Physiol. Scand; 47: 350-361.

Bharati sinha, Natu AA and Nanavati DD., 1982. Prenylated flavonoids from

Tephrosia purpurea seeds. Phytochem; 21: 1468-70.

Bhattacharjee SK.,1999 Hand Book of Medicinal Plants. Pointer Publication.

68-69.

Bhattacharya SK, Satyan KS, Ramanthan M., 1999. Experimental methods for

evaluation of Psychotropic agents in rodents. II antidepressants. Indian J. Exp

Biol; 37:120.

Bhattacharya S, Haldar PK, Zaman MD., 2010. Anti-inflammatory and invitro

Antioxidant Property of Zanthoxylum nitidum root. Current Trends in

Biotechnology and Pharmacy; 4(3):774-783.

Birkmayer JGD, Vreck C, Volc D, Birkmaye W., 1993. Nicotinamide

dinucleotide (NADH) a new therapeutic approach to Parkinson’s disease,

comparison of oral and Pareneral application. Acta Neurol Scan 87; 146: 32-35.

Blois MS., 1958. Antioxidant determination by the use of stable free radical.

Nature; 26: 1199-1200.

Bibliography


Blois MS., 2001. Antioxidant activity of grape seeds extracts on peroxidation

models invitro. J. Agro Food Chem; 55:1018.

Bocharov EV, Kucheryanu VG, Kryzhanav Skii GN, Bocharova OA, Kudrin VS,

Belorustseva SA., 2006. Effect of complex phytoadaptogen on MPTP-induced

Parkinson’s syndrome in mice. Bulletin of Experimental Biology and Medicine;

141(5): 495-498.

Bopaiah CP and Pradhan N., 2001. Central nervous system stimulatory action

from the root extract of Plumbago zeylanica in rats. Phytother Res; 15(2): 153-

156.

Bonnet AM and Houeto JL., 1999. Pathophysiology of Parkinsons disease. J.

Biomed and Pharmacother; 53:117-121.

Bredesen DE., 1995. Neural apoptosis. Ann. Neurol; 38: 839-851.

Brown RG and Marsden CD., 1988. “Subcortical dementia”. The neuro-

psychological evidence. Neuroscience; 25: 363-387.

Bruce A, Freeman D and James C., 1982. Biology of disease-free radicals and

tissue injury. Lab. Invest; 47: 412-426.

Burkart A., 1976. A monograph of the genus Prosopis. Journal of Arnold

Arboretum; 57 (3), 219-249. 57 (4) 450-525.

Burkill HM., 1985. The useful plants of west Tropical Africa. UK: Royal Botanic

Garden Kew, 1960.

Burns RS, Chiuch CC, Markey SP, Ebert MH, Jacobo witz DM and Kopin IJ.,

1983. A primate model of Parkinsonism: Selective destruction of dopaminergic

neurons in the pars compact a of the substantia nigra by N-methyl-4-phenyl-

1,2,3,6-tetrahydropyridine. Proc. Natl.Acad. Sci.; 80: 4546-4550.

Bibliography


Carlini CR and Guimaraes JA., 1981. Isolation and characterization of a toxic

protein from Canavalia ensiformis (Jack bean) seeds, distinct from Con Canavalin

A. Toxicol; 19: 667-675.

Carlini CR and Guimaraes JA., 1991. Plant and microbial toxic proteins as

hemilectins; emphasis on conatoxin. Toxicol; 29: 791-806.

Caro LA, Polci PA, Lindstrom LI, Echenique CV and Hernandez LF., 2002.

Micro propagation of Prosopis chilensis (MOL.) Stuntz from young and mature

plants. Biocell; 26 (1): 25-33.

Castagnoli KP, Steyn SJ, Petzer JP, Vander Schyf CJ, Castagnoli N Jr., 2001.

Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a

compound isolated from tobacco Chem. Res Toxicol; 14 (5): 523-527.

Chaudary SR, Chavan MJ, Gaur RS.,2004. Antiinflammatory and Analgesic

activity of Capparis zeylanica root extracts. Ind J Natural Products; 20 (1): 36-

39.

Chen.JL, Blanc.P, Stoddart.CA, Bogan.M, Rozhon.EJ, Parkinson.N., 1998. New

iridoids from the medicinal plants Barleria prionities with potent activity against

respiratory syncytial virus. J. Nat Prod; 612: 1295-7.

Chinagala G, Alvarez FJ, Probst A, Palacois JM., 1992. Mesotriatal and

Mesolimbic dopamine uptake binding sites are reduced in Parkinson’s disease and

progressive supranuclear palsy: a quantitative autoradiographic study using (³H)

mazindol. Neuroscience; 49: 317-327.

Chopade VV, Tankar AN, Ganjiwale RO, Yeole PG., 2008. Antimicrobial

activity of Capparis zeylanica roots. International Journal of Green Pharmacy;2

(1): 28-30.

Chrungo VJ, Singh K, Singh J (1980). Silymarin mediated differential modulation

of toxicity induced by haloperidol and related antipsychotic drugs. Clin Ter;

95(2): 157-164.

Bibliography


Cohen G and Warner P., 1984. Free radicals, oxidative stress and neuro-

degeneration. In, Neurodegenerative Diseases (Calne DB) Saunders, Philadelphian:

139-161.

Cohen G., 1983. The Pathobiology of Parkinson’s disease: Biochemical aspects

of dopamine neurons senescence. J. Neural Transm ; 19: 89-103.

Corbin KB., 1949. Trihexyphenyl: Evaluation of new agent in the treatment of

Parkinson’s disease JAMA; 141: 373-381.

Cousin. MS, Salamone JD., 1996. Skilled motor deficits in rats induced by

ventrolateral striatal dopamine depletions: behavioral and pharmacological

characterization, Brain.Res; 732: 186-94.

Crary M, Groher M., 2000. Post CVA dysphagia on ADVANCE for Speech –

Language Pathologist. Phytomedicine; 7 (4): 259-63.

Crossland J., 1980. Lewis pharmacology, Churchill Livingstone, New York,

PP.137.

Cui JG, Holmin S, Mathiesen T, Meyerson BA, Linderoth B., 2000. Possible role

of inflammatory mediators in tactile hypersensitivity in rat models of

mononeuropathy pain. 88 (3): 239-248.

Cummings JL., 1992. Depression and Parkinson’s disease: A review. J.

Psychiatry; 149: 443-454.

Daisuke Y, Kenzo N, Tadashi AT., 1988. Nucleotide sequence of cDNA for

Concanavalin A from Canavalia gladiata using plasmid. European Journal of

Biochemistry; 170 (3): 515-520.

Daisuke Y, Takao M., 1986. Plant and cell physiology; 27(6): 1033-1041.

Damintoti K, Mamoudou HD, Jacques S and Alfred ST., 2005. Antioxidant and

antibacterial activities of polyphenols from ethnomedicinal plants of Burkina

Faso. Afri. J. Biotechnol; 4: 823-28.

Bibliography


Dandiya PC and Chopra YM., 1970. CNS acting drugs from plants indigenous to

Ind. Journal. Pharmacol; 2: 67-90.

Daniel M, Robert BMR, Gumbman PVH, Neukom RM, Saunders., 1986.

Processing, composition, nutritional evaluation and utilization of mesquite

(Prosopis spp.) pods as a raw material for the food industry. J. Agric. Food Chem;

34 (5): 914-919.

Davies AM., 1995. The Bcl-2 family of proteins and the regulation of neuronal

survival. Trends Neurosci; 18: 355-38.

Del valle FR, Marco E, Becker R, Saunders RM., 1987. Development and

evaluation of a procedure to produce mesquite (Prosopis spp.) pod protein-

concentrate. J. Food Process. Preserv. 11: 237-246.

Detke MJ, Rickels M, Lucki I., 1995. Active behaviour in the rat forced

swimming test differentially produced by serotonergic and noradrenergic

antidepressants. Psychopharmacol; 121: 66-72.

Dhawan BN., 1995. Centrally acting agents from Indian Plants. In: Koslow SH,

Murthy Rs, Coelho GV (Eds). Decade of the Brian: India/USA Research in

Mental Health and Neurosciences. Rockville: National Institute of Mental Health;

197-202.

Dimauro S., 1993. Mitochondrial involvement in Parkinson’s disease. The

controversy continues. Neurology; 43: 2170-2172.

Dimonte DA, Wu EY, Irwin I, Delanney LE and Langston JW., 1992. Production

and disposition of 1-methyl-4-phenylpyridinium in primary cultures of mouse

astrocytes. Glia; 5 (1): 48-55.

Doo AR, Kim SN, Park JY, Cho KH, Hong J, Eun-Kyung K, Moon SK, Jung

WS, Lee H, Jung JH, Park HJ., 2010. Neuroprotective effects of an herbal

medicine, Yi-Gan San on MPP(+)/MPTP induced cytotoxicity invitro and invivo

J. Ethnopharmacol.; 31 (2): 433-442.

Bibliography


Dorshay LJ and Constable K., 1949. Active therapy for Parkinsonism, JAMA;

140: 1317-1322.

Duke JA., 1993. Medicinal plants and the pharmaceutical Industry. In: J. Janic

and J. E. Simon (eds), New Crops, Wiley, New York; 664-669.

Duman RS, Heminger GR, Nestler ER., 1994. Effect of ethanol extract of

Indigofera tinctoria Linn on molecular psychiatry. J. Neurosci; 14: 3413-3425.

Dunham NW, Miya TSJ., 1957: altered cholinergic metabolism in rat CNS. Am

pham Assoc Sci ; 46: 208-209.

Duvoisin RC., 1998. Role of genetics in the cause of Parkinson’s disease. Mov.

Disord; 13 (1): 7-12

E1-Tahir.KE, Ashour. MM and A1-Harbi. MM., 1993. The cardiovascular actions

of volatile oil of the black seeds (Nigella sativa) in guinea-pigs.elucidation of the

mechanism of action. General Pharmacol; 24: 1123-31.

Eisa MM, Almagboul AZ, Omer MEA, and Elegami AA., 2000. Antibacterial

activity of Dichrostachys cinerea. Fitoterapia; 71 (3): 324-327.

Ellman GL., 1959. Tissue sulfhydryl groups. Arch Biochem Biophys; 82: 70-77.

Elsworth JD, Dentch AY Redmond DE, Sladek J R and Roth RH., 1987. Effects

of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and

metabolites in Primate brain and CSF. Brain Res; 415: 293-299.

Estevez AM, Escobar B, Ugarte V., 2000. Use of mesquite cotyledon (Prosopis

chilensis (Mol) Shuntz) in the manufacturing of cereal bars). Arch latinoam Nutr;

50(2): 148-51.

Fahn S and Cohen G., 1992. The oxidant stress hypothesis in Parkinson’s disease:

Evidence supporting it. Ann. Neurol; 32: 804-812.

Bibliography


Fahn S., 1991. An open trial of high dosage antioxidats in early Parkinson’s

disease. Am. J. Cli Nut ; 53(1): 380S-382S.

Fahn S., 1999. Parkinson’s disease, The effect of levodopa and the ELLDOPA

trail. Earlier Vs. later L-DOPA. Arch. Neurol; 56: 529-535.

Fearnely J and Lees A., 1994. Pathology of Parkinson’s disease. In

neurodegenerative disease (Calne, DB., ed.). Saunders, Philadelphia: 545-554.

File SE, Wardril AG., 1975. Validity of Head Dipping as a measure of

exploration in a modified Hole Board. Psychopharmacology; 44: 53-59.

Flint Beal M, Anthony E, Lang, Albert C, Ludolph., 2002. Neurodegenerative

disease and neurobiology, pathogenesis and therpeutics, Arch Neurol; 59: 1541-

1550.

Forno LS, Langsto JW, Delanney LE and Irwin I., 1988). An electron

microscopic study of MPTP induced inclusion bodies in an old monkey. Brain

Res; 488: 150-157.

Forno LS, Langston JW, Delanney LE, Irwin I and Ricaurte GA., 1986. Locus

coeruleus lesions and eosinophilic inclusions in MPTP treated monkeys. Am

Neurol; 20: 449-455.

Frau L, Borsini F, Wardas S, Khairnar AS, Schintu N, Morelli M., 2010.

Neuroprotective and antiflammstory effects of the adenosine A(2A) receptor

antagosnist ST1535 in a MPTP mouse model of Parkinson’s disease. Pubmed,

NCBI; 65 (3): 181-188.

Frucht S, Rogers JG, Greene PE, Grodon ME and Fahn S., 1999. Falling asleep

at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole

Neurology; 52: 1908-1910.

Fujikawa T, Soya H, Hibasami H, Kawashima H, Takeda H, Nishibes Nakashima

K., 2002. Effect of Acanthopanax senticosus harms on bipgenic monoamine

levels in the rat brain. Phy. Ther. Res; 16 (5): 474-478.

Bibliography


Gagne B, Gelinas S, Bureau G, Lagace B, Ramassam C, Chiasson K, Valastro B,

Martinoli MG., 2003. Effect of estradiol, phytoestrogens and Ginkgo biloba

extracts against 1-methyl-4-phenyl-pyridine-induced oxidative stress. Endocrine;

21(1): 89-95.

Gainetdinov.R.R, Fumagalli.F, Jones.SR, Caron.M.G., 1997. Dopamine transporter

is required for the invivo MPTP neurotoxicity evidence from mice lacking the

transporter. J.Neurochem; 69: 1322-1325.

Gang z, Zhi HJ, Xiang WZ, Shao YZ and Li HG., 2008. Dopamine transporter

inhibitory and antiparkinsonian effect of common flowering quince extract.

Pharmacol Biochem and Behavior; 90(3): 363-371.

Gerlach J., 1991. New antipsychotics: Classification, efficacy and adverse effects

Schizophr. Bull;17: 289-309.

Gerlach M, Jellinger K and Riederer P., 1994. The possible role of noradrenergic

deficits in selected signs of Parkinson’s disease. In: Briley M, Marien M, eds

Noradrenergic mechanism in Parkinson’s disease. CRC Press Boca Raton; 59-71.

German DC, Nelson EC, Liang CL, Speciale SG, Sinton CM, Sonsalla PK., 1996.

The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 & A10

dopaminergic neurons in the mouse. Neurodegeneration; 5: 299-12.

Ghule BV, Murugananthan G, Yeole PG., 2007. Analgesic and Antipyretic

effects of Capparis zeylanica leaves. Fitoterapia; 78(5): 365-369.

Ghule BV, Murugananthan G, Nakhat PD, Yeole PG., 2006. Immunostimulant

effect of Capparis zeylanica leaves. J. Ethanopharmacol; 108(2): 311-315.

Gibb WR., 1992. Neuropathology of Parkinson’s disease and related syndromes.

Neurol Clin; 10: 361-376.

Giros B, Caron M., 1993. Molecular Characterization of the dopamine transporter.

Trends Pharmacol Sci; 14: 43-49.

Bibliography


Giros B, Caron MG., 1993): Molecular characterization of the dopamine

transporter. Trends Pharmacol Sci; 14: 43-49.

Giuseppe P, Piero P, Vincenzo P, Daniela C, Gianluigi V and Emanuele A., 1994.

The effect of silymarin on Plasma levels of malon dialdehyde in patients

receiving long-term treatment with Psychotropic drugs. Current Therapeutic

Research; 55(5): 537-545.

Goetz CG., 1990. Dopaminergic agonists in the treatment of Parkinson’s disease,

Neurology; 40(1): 50-54.

Goetz CG., 1998. Influence of COMT inhibition on levodopa pharmacology and

therapy. Neurology; 50: 526-530.

Golbe LI., 1999. Alpha-Synucein and Parkinson’s disease. Mov Disord; 14: 6-9.

Goodman and Gilman’s A., 2001. The pharmacological basis of therapeutics,

international 10th

ed., MC Graw-Hill companies; 549-568.

Goyal RK., 2005-2006. Practical in Pharmacology. 5th

ed: B.S.Shah Prakashan

Ahmedabad; 121-122.

Graham DC., 1978. Oxidative pathways for Catecholamines in the genesis of

neuromelanin and cytotoxic quinones. Mol Pharmacol; 14: 633-643.

Greenamyre JT and O Brien CF., 1991. N-Methyl-D-Aspartate antagonists in the

treatment of Parkinson’s disease. Arch.Neurol; 48: 977-981.

Grubben GJH and Denson.OA., 2004. Plant Resources of tropical Africa. Nordic.

J Botany; 23(3): 298-291.

Gujral ML, Saxena PN, Mishra SS., 1995. Experimental study of the comparative

activity of indigenous diuretics. J Indian Med Assoc; 25:49.

Bibliography


Gupta G, Avtar CR., 2010. Synergistic effect of Withania somnifera dunal and L-

dopa in the inhibition of haloperidol-induced catalepsy in mice, Pharmacog. Mag.

5(19): 46-50.

Gupta HM, Saxena VK., 1984. Chemical examination of the glyceride contents of

the root of Barleria prionities Linn: Bulletin of Medico-Ethno Botanical research;

5(3):178-83.

Gupta RS, Kumar P, Dixit VP, Dobhal MP., 2000. Antifertility studies of the root

extract of the Barleria prionities Linn in male albino rats with special reference to

testicular cell population dynamics. J Ethnopharmacol; 70: 111-7.

Gustaro AB, Jaiana MO, Frederi CB, Batista M., 2007. Structural analysis of

Canavalia maritime and Canavalia gladiate lectins complexed with different

dimannosides: New insights into the understanding of the structure biological

activity relationship in legume lectins. J. Structural Biol; 160: 168-176.

Gutteridge JMC and Halliwell B., 1990. The measure and mechanism of lipid

peroxidation in biological system. Trends Biochem Sci; 15: 129-135.

Gybels J M., 1994. Defining idiopathic Parkinson’s disease. In Noradrenergic

mechanisms in Parkinson’s disease. (M.Briley and M.Marien,Eds) CRC Press,

Boca Raton, 1-9.

Halliwell B, Gurreridge JMC., 1989. Free radicals in biology and Medicine, 2nd

CD, Oxford, Clarendon press.

Harborne JB and Williams CA., 1983. Flavonoids in the seeds of Argemone

mexicana. Phytochem; 22: 1520-21.

Harborne JB., 1998. Phytochemical Methods, A Guide to Modern Techniques of

Plant Analysis, Springer (India) Pvt. Ltd; New Delhi.

Harman.D., 1991. The aging process major risk factors fro health and disease

proc. Natl Acad Sci; 88: 5360-5363.

Bibliography


Heikkila RE, Manzino L, Cabbat FS and Duvoisin RC., 1984. Protection against

the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

by monoamine oxidase inhibitors. Nature; 11: 467-469.

Heikkila RE, Sonsalla PK and Duvoisin RC., 1989. Biochemical models of

Parkinson’s disease. In Neuromethods, Drugs as Tools in Neuroscience Research.

(AB Boutton, GB Baker and AV Juorio, Eds); Humana Press, Clifton NJ; 12:

351-384.

Hein L, Kobilka BK., 1995. Neurotransmitter receptors IV. Neuropharmacology;

34(4): 357-366.

Heller B, Fischer E, Martin R., 1976. Therapeutic action of D-Phenylalanine in

Parkinson’s disease Arzneimittle for schung; 26: 577-579.

Henry B, Rachel G, Richard H, Joseph M., 1997. Lippincott’s, Illustrated

Reviews, Pharmacology 2nd

ed: 81-88.

Henry LEA, Halliwell B and Hall DO., 1976. The superoxide dismutase activity

of various photosynthetic organisms measured by a new and a rapid assay

technique. FEBS Lett; 66 : 303.

Hersch SM, Guteksunst CA, Rees HD, Heilman CJ and Levey AI., 1994.

Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and

electron microscopic immunocytochemistry using subtype specific antibodies. J

Neurosci; 14: 3351-3363.

Hironori Y, Ryohei Y, Hayato K, Tatsuya T, Hiroto U, Hiroyuki K, Jiro K,

Trustomu A., 2010. Therapeutic effect of a novel antiparkinsonian agent

Zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neuro-

toxicity in mice. Metab Brain Dis; 25: 135-143.

Hoehn MM and Yahr MD., 1967. Parkinsonism: Onset progression and mortality.

Neurology; 17: 427-442.

Bibliography


Horniykiwicz O., 1960. Biochemical Pathophysiology of Parkinson’s disease.

Adv Neurol ; 45: 19-34.

Hornykiewicz O., 1973. Metabolism of dopamine and L-dopa in human brain. In

frontiers in catecholamine Research (E-Usdin and Snyder SH) Pergamon press,

New York: 1101-1107.

Hornykiewicz O., 1974. The mechanisms of action of L-dopamine in Parkinson’s

disease. Life Sci; 15: 1249-1259.

Houghton PJ, Zarka R, Dela Heras B and Hout JRS., 1995. Fixed oil of Nigella

sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and

membrane lipid peroxidation. Planta Medica;61: 33-36.

Hussain.G, Manyam.BV., 1997. Mucuna pruriens proves more effective than

L-dopa in Parkinsons disease animal model. Phytotherapy Research;11(6): 419-423.

Ialenti A, Moncada S and Di Rosa M., 1993. Modulation of adjuvant arthritis by

endogenous nitric oxide. Br J Pharmacol; 110:701-706.

Ingle PK., 2003. L-dopa bearing plants, Natural Product Radiance; 2(3): 126-133.

Innamorato NG, Jazwa A, Rojo AI, Garcia C, Fernadez-Ruiz J, Grochot-Przeczek

A, Stachurska A, Jozkowicz A, Dulak J, Cuadrado A., 2010. Different

susceptibility to the Parkinson’s toxin MPTP in mice lacking the redox master

regulator NrFz (or) its target gene heme oxygenase1. PLOS one, 28; 5(7):

e11838.

Ioanne E, Nash, Michael P, Hill and Jonathans MB., 1999. Antiparkinsonian

action of blockade of NR2B containing NMDA receptors in the reserpine treated

rat. Experimental Neurology; 155(1): 42-48.

Ishikawa T, Funahashi T, Kindo J., 2000. Effectiveness of the Kampo kami-shoyo-

san (TJ-24) for tremor of antipsychotic-induced Parkinsonism Psychiatryclin.

Neurosci; 54(5): 579-582.

Bibliography


Ivanova D, Gerova D, Chervenkov T and Yankova T., 2005. Polyphenols and

antioxidants capacity of Bulgarian medicinal plants. J Ethnopharmacol; 96: 145-

150.

Jaiswal AK, Bhattacharya SK and Acharya SB., 1994. Anxiolytic activity of

Azadirachta indica leaf extract in rats. Indian J Exp Biol; 32: 489-491.

Jarvie KR and Caron MG., 1993. Heterogeneity of dopamine receptors. Adv

Neurol; 60: 325-333

Javitch JA, D’amato RJ, Strittmatter SM, Snyder SH., 1985. Parkinsonism

inducing neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine:uptake of the

metabolite N-methyl-4-phenyl-pyridine by dopamine neuron explains selective

toxicity. Proc Natl Acad Sci USA;82: 2173-2177.

Jeffrey N, Joyce, Cheryl W, Han R, Sabine B and Diane H., 2004. Low dose

pramipexole is neuroprotective in the MPTP mouse model of Parkinson’s disease

and down regulates the dopamine transporter via the D3 receptor. BMC, Biology;

2:22.

Jenner P, Dexter DT, Sian J, Schapira AHV and Marsden CD., 1992. Oxidative

stress as a cause of nigral cell death in Parkinson’s disease and incidental lewy

body disease. Ann Neurol; 32: 582-587.

Jenner P., 1998. Oxidative mechanism in nigral cell death in Parkinson’s disease.

Mov Disord; 13(1): 24-34.

Jin CF, Shen SR, Zhao BI., 2001. Different effects of five catechine on 6-OHDA-

induced apoptosis in PC 12 cells. J. Agri and Food Chem; 49 (12): 6033-6038.

Jo YS, Huong DT, Bae K, Lee MK, Kim YH., 2002. Monoamine oxidase

inhibitory coumarin from Zanthoxylum schinifolium. Palnta Med; 68(1): 84-85.

Bibliography


Kahn MM, Hoda MN, Ishrat T, Ahmad A, Khan MB, Khuwaja G, Raza SS, Safhi

MM, Islam F., 2010. Amelioration of MPTP induced behavioural dysfunction and

oxidative stress by pycnogenol in mouse model of Parkinson’s disease. Behav.

Pharmacol ; 21(5-6): 563-71.

Kakrani HN, Saliya AK., 1994. Traditional treatment through herbs in kutch

district, Gujarat sate, India Part-II: Analgesic, anti-inflammatory, antirheumatic,

antiarthritic plants. Fitoterapia; 5: 427.

Kamal R and Mangla M., 1993. Invivo and Invitro investigations on rotenoids

from Indigofera tinctoria L and their bio efficacy against larvae of Anapheles

stephansi and adults of Callosobruchus chinensis. J . Biosci; 18: 93-101.

Kamalakkannan N and Stanley Mainzen Prince P., 2003. Effect of Aegle

marmelos fruit extract on tissue antioxidants in streptozotocin diabetic rats. Indian

J Exp Biol; 41: 1288.

Kannur DM., 2006. Herbal drugs in parkinsons disease. Pharmainfo.net; 4(5):

Kari HP, Dvidson PP, Herbert HH and Kochbar MH., 1978. Effect of Ketoamine

on brain monoamine levels in rats. Res Comm Chem Path Pharmacol; 20:475-

488.

Kells AP, Eberling J, Sux, Pivirotto P, Bringas J, Hadaczek P, Narrow WC,

Bowers WJ, Federoff HJ, Forsayeth J, Bankiewicz KS., 2010. Regeneration of the

MPTP- lesioned dopaminergic system after convection - enhanced delivery of

AAV2-GDNF. J Neurosci; 30(28): 9567-9577.

Kempster PA, Bogetic Z, Secombe JW, Martin HD, Balazz NDH, Wahlqvist

ML., 1992. Motor effects of broad beans. J Neurol Neurosurg Psychiatry; 55:

725-727.

Keyser DL and Rodnitzky RL., 1991. Neuroleptic malignant syndrome in

Parkinson’s disease after withdrawal or alteration of dopaminergic therapy. Arch

Intern Med; 151: 794-796.

Bibliography


Khan., 2010. Selenium partially reverses the depletion of straital dopamine and its

metabolites in MPTP treated C57BL mice. Neurochem. Int; 57(5): 489-491.

Khandelwal KR., 1998. Practical pharmacognosy, 6th

ed., Nirali Prakashan, Pune:

171-172.

Khanna N, Goswami M, Sen Pand Ray A., 1995. Effect of Some indigenous

drugs on pair models in mice. Ind J Pharmacol; 27:60.

Khare CP., 2004. Encyclopedia of Indian Medicinal Plants. Springer Verlag.,

Heidelberg; New York: 124.

Kim HG, Ju MS, Kim DH, Hong I, Cho SH, Cho KH, Park W, Lee EH, Kim SY,

Oh MS., 2010. Protective effects of chunghyuldam against Ros-mediated

Neuronal cell death in models of Parkinson’s disease. Basic Clin Pharmacol

Toxicol; 107(6):925-930

Kim MS, Lee JI, Kim SE., 2004. Neuroprotective effect of Ginkgo biloba leaf

extract in a rat model of parkinson’s disease. Phy Ther Res; 18(8): 663-666.

Kirtikar KR and Basu BD., 1995. Indian Medicinal plants. Vol III; International

Book Distributors, Dehradun, India. pp.1876-1877.

Kirtikar KR, Basu BD., 1995. Indian Medicinal Plants. Vol. 1; (2nd edition),

International Book Distributors; Dehradun. India. pp 790-791.

Kirtikar KR, and Basu BD., 1987 Indian Medicinal Plants, Vol. 2, International

Book Distributors, Dehradun, India, pp. 912-913.

Kirtikar KR and Basu BD., 1980. Indian Medicinal Plants, Vol. 1, 2nd

(ed.)., B.

Sing, MP. India. 756-759.

Kish PE, Fisher BA and Ueda T., 1989. Active transport of r-amino butyric acid

and glycine into synaptic vesicles. Proc Natl Acad Sci USA; 86: 3877-3881.

Bibliography


Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S.,

1998. Mutations in the parkin gene cause autosomal recessive juvenile

Parkinsonism. Nature; 392: 605-608.

Kitayama S, Shimada S and Uhl GR., 1992. Parkinsonism inducing neurotoxin

MPP+: Uptake and toxicity in nonneuronal cos cells expressing the dopamine

transporter cDNA. Ann Neurol; 32: 109-111.

Kokate CK, Purohit AP, Gokhale SB., 2002. Test Book of Pharmacognosy, 19th

ed, Nirali Prakasan, Pune, 108-109.

Kolb B and Whishaw IQ., 1990. Fundamentals of Neuropsychology, 3rd

ed;

chapter 21, memory, Freeman and company, New York; pp.525-567.

Kopin IJ., 1993a. Parkinson’s disease: Past present and future Neuropsycho-

pharmacology; 9: 1-12.

Kopin IJ., 1993b. The pharmacology of Parkinson’s disease therapy. An update.

Rev Pharmacol; 32: 467-495.

Kulkarni SK., 1987. Hand book of experimental pharmacology, Vallabh

Prakashan, New Delhi, India; pp. 122.

Kurth MC., 1997. Tolcapone improves motor function and reduces levodopa

requirement in patients with Parkinson’s disease experiencing motor fluctuations:

a multicentre, double-blind, randomized, Palcebo-controlled trial. Neurology; 48:

81-87.

Kusum Devi V, Kshama Devi, Sameer KS., 2004. Plant based medications for

Parkinsonism. Pharma Times; 36: 41-45.

Lang AP, Lozano AE., 1998. Parkinson’s disease, New Engl J. Med; 339:1044-

1053.

Bibliography


Langston JW, Forno LS, Robert CS and Irwin I., 1984a. Selective nigral toxicity

after systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

(MPTP) in the squirrel monkey. Brain Res; 292: 390-394.

Langston WJ., 1985. MPTP and Parkinson’s disease. Trends Neurosci; 8: 79-83.

Laxminarain M and Hildebert W., 2007. Extraction of bioactive principles from

Mucuna pruriens seeds. Indian journal of Biochemistry and Biophysics; 44: 56-

60.Leonard BE., 1992. Fundamental of Psychopharmacology Wiley, New York.

Lewis JV, Jacowec M, Burke RE, Przedborski S., 1995. Time course and

morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-

4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegenration; 4:257-69.

Li C, Biswas S, Li X, Dutta AK, Le W., 2010. Novel D3 dopamine receptor -

preferring agonist D-264. Evidence of neuroprotective property in Parkinson’s

disease animal models induced by MPTP and lactacystin, J. Neurosci Res; 88(11):

2513-2523.

Lipton SA, Rosenberg PA., 1994. Excitatory amino acids as a final common

pathway for neurologic disorders New Engl. J. Med; 330: 613-622.

Longston JW, BallardPA, Tetrud JW and Irwin I., 1983. chronic parkinsonism in

humans due to a product of meperidine analog synthesis Science (wash.DC);

219: 979-980.

Lowry OH, Rose brough NJ, Farr AL and Randall RJ., 1951. Protein

measurement with folin phenol reagent. J Biol-chem; 193: 265-275.

LU Y and Foo LY., 2001. Antioxidant activity of polyphenols from sage (Salvia

officinalis). Food Chem ;75: 197-202.

Madhava Chetty K, Sivaji K, Tulasi Rao K., 2008. Flowering plant of Chittoor

District, Andhra Pradesh, India; Students Offset Printers, pp. 82.

Bibliography


Mandair NS, Harris PJC., 2003. Folial nutrition of invitro-cultured Prosopis

chilensis (Molina) Stuntz shoots. Plant;39(2):240-244

Mangathayaru K, Sravan K, Praveen A, Reddy KR, Munikumar, Swetha B and

Umamaheswara reddy C., 2007. Invitro antioxidant studies of the aerial parts of

Origanum majoram Linn and Artemesia Sievesiana. Ehrh. Phcog Mag;3: 90-94.

Mann A, Gbate M, and Umar A., 2003. Medicinal and Economic plants, Jube

Evans Books, Bida, Nigeria, pp. 161.

Marcocci L, Packer L, Droy-Lefaiz MT, Sekaki A and Garder-Albert M., 1994.

Antioxidant action of Ginko biloba extract, Meth Enzymol. Egb; 761: 234, 462.

Marini AM, Lipsky RH, Schwartz JP and Kopin IJ., 1992. Accumulation of 1-

methyl-4-phenyl-1,2,3,6-tetrahydropyridine in cultured Cerebellar astrocytes. J

Neurochem; 58: 1250-1258.

Marx JL., 1987. Oxygen free radicals linked to many diseases. Science; 235, 529.

Mary AL., 1995. An alternative medicine treatment for Parkinson’s disease:

results of a multicenter clinical trial.HP-200 in Parkinson’s disease study group. J.

of Alterna. Complment Med; 1(3): 249-55.

Maureen RA., 1997. Seeking drugs in Natural Products, Chem and Eng News;

14-28.

Mayeux R, Stern Y, Cote L, B.W. William J., 1984. Altered serotonin metabolism

in depressed patients with Parkinson’s disease. Neurology; 34 (5): 642.

Mc Chesney JM., 1997. The promise of plant derived natural products for

development of new pharmaceuticals, Pharm. News; 4(3): 14-18.

Medicana R, Janssens J and Tarasenko A., 1997. Anti-angiogenic activity of

Nigella sativa plant extract in cancer therapy. Annual meeting of the Am Assoc

Cancer Res; 38: A1377.

Bibliography


Mehanjani SS, Doshi VJ, Parikh KM, Manyam BV., 1996. Bioavailability of

L-dopa from HP-200. Phy Ther Res; 10: 254.

Meininger V, Flamier A, Phan T, Ferris O, Uzan A, Lefur G., 1982. L-Methionine

treatment of Parkinson’s disease. Preliminary results. Rev Neurol (Paris); 138(4):

297-303.

Melwyn DC and Ramaiah SK., 2010. L-Cananine and L-Arginine in two wild

legumes of the genus Canavalia. Journal of IIOAB; 1(2) : 0976-3104.

Merry DE, Korsmeyer SJ., 1997. Bcl-2 gene family in the nervous system. Annu

Rev Neuurosci; 20: 245-267.

Mills S, Kerry, B.Ed., 2000. Principles and Practices of Phytotherapy. Churchill

Livingstone NY, 22-25.

Mink JW and Thach WT., 1993. Basal ganglia intrinsic circuits and their role in

behavior. Curr Opin Neurobiol; 3: 950-957.

Misra L, Mishra HO, Wagner H., 2004. Biologically active principles from

Mucuna pruriens seeds. IUPAC international conference on biodiversity and

natural products chemistry and medicinal applications; 26-31: 213.

Mohanasundari M, Sathiupathy S, Sabesan M., 2006. The effect of Hypericum

perforatum extract against the neurochemical and behavioural changes induced by

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice. Indian J Pharmacol;

38(4): 266-270.

Mohd Abid HJ, Harish K, Mohammed A., 2006. Pharmacological Evaluation of

Pachyorhizus erosus (L) seeds for central nervous system depressant activity,

Indian J Physiol Pharmacol; 50(2): 143-151.

Montastruc JL, Rascol O and Senard JM., 1993. Current status of dopamine

agonists in Parkinson’s disease management. Drugs; 46: 384-393.

Bibliography


Moratalla R, Quinn B, Delanney LE, Irwin I, Langston JW and Graybiel AM.,

1992. Differential vulnerability of primate caudate putamen and striosome matrix

dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-

tetrahydropyridine. Proc Natl Acad Sci USA; 89: 3859-3863.

Moreno SR.F, Feliciano GD, Freitas RS, Farah MB, Laurentino Filho GL, Rocha

EK, Jales RLC, Bernardo-Filho M., 2002. Effect of Ginkgo biloba on the labeling

of blood elements with technetium-99m: invitro study. Rev. Bras. Farmacogn 12:

62-63.

Mouradian MM and Chase TN., 1994. Improved dopaminergic therapy of

Parkinson’s disease. In, movement disorders 3. Butterworth-Hienemann, 181-199

Mullyla VV, Sotaniemi KA, Vuorienen JAAND Heinonen EH., 1992. Selegiline

as initial treatment in in de novo parkinsonian patients. Neurology; 42: 339-343.

Nadakarni AK., 1976. Indian Materia Medica. Vol. I, Popular Prakashan Pvt.Ltd.,

Bombay. pp.175-177.

Nagarjun S, Barnabas CGG., 1986. Antimicrobial activity of flavanoids of plant

extracts. Fitoterapia; 59(6): 508-510.

Nahmias C, Garnett ES, Firnau G, and Lang A., 1985. Striatal dopamine

distribution in Parkinsonian patients during life. J Neurol Sci; 69: 223-230.

Narendar.T, Khalid.T, Anju Purib and Ramesh Chandra., 2006. Antidyslipidemic

activity of furano-flavonoids isolated from Indigofera tinctoria. Bioorganic and

Medicinal Chemistry letters;16:3411-14.

Niznik HB, Fogel EF, Fassos F, Seeman P., 1991. The dopamine transporter is

absent in Parkinsonian putamen and reduced in the caudate nucleus. J

Neurochem; 56: 192-198.

Ohkawa H, Ohishi N and Yagi K., 1979. Assay for lipid peroxides in animal

tissues by thio barbituric acid reaction. Anal Biochem; 95: 351.

Bibliography


Ohkowa N, Ohishi H and Yagi., 1979. Assay of lipid peroxides in animal tissue

by thiobarbituric acid reaction. Anal Biochem; 95: 331-335.

Oke JM and Hamburger MO., 2002. Screening of some Nigerian medicinal plants

for antioxidant activity using 2,2-Diphenyl picrylhydrazyl radical. African J

Biomed Res; 5: 77-79.

Olanow CW, Schapira AHV, Rascolo., 2000. Continuous dopamine receptor

stimulation in early Parkinson’s disease. TINS; 23: 117-26.

Olanow CW., 1990. Oxidation reactions in Parkinson’s disease. Neurology; 40(l):

32-37.

Olanow CW., 1993. MAO-B inhibitors in Parkinson’s disease. Adv. Neurol; 60:

666-671.

Olayiwala A., 1992. WHO Guidelines for the Assessment of Herbal Medicines.

Fitoterapia; 1( 2):

Olney JW., 1990. Excitotoxic amino acids and neurosychiatric disorders. Annu

Rev Pharmacol Toxicol; 30: 47-71.

Oomachan. MM., 1991. Ethno-botanical and conservation aspects of medicinal

plants of Madhya Pradesh. Ind. J. Pure and Appli Sci; 6: 39 43.

Palav YK, Priscilla MD., 2006. Standardization of selected Indian Medicinal

herbal raw materials containing polyphenols as major phytoconstituents. Ind. J.

Pharm. Sci.; 68(4):506-509.

Panwar HS, Nauriyal MM, Joshi HC., 1979. Invitro screening of certain

indigenous plants for their antimycotic activity. Veterinary Res Bull;2: 164-7.

Pavasilion PS, Cotzias GC, Duby SE, Stech AI, Fehling C and Bell MA., 1972.

Levodopa in parkinsonism. Potention of central effects with peripheral inhibitors.

New Engl J Med; 286: 8-14.

Bibliography


Parekh J and Chanda S., 2007. Invitro screening of antibacterial activity of

aqueous and alcoholic extracts and various Indian plant species against selected

pathogens from enterobacteriaceae. Afri. J. Micro. Res;1(6): 092-099.

Parkinson study group., 1993. Effect of tocopherol and deprenyl on the progression

of disability in early Parkinson’s disease. N Engal J Med; 328: 176-183.

Parkinson study Group., 1997. Entacapone improves motor fluctuation in

levodopa treated Parkinson’s disease patients. Ann Neurol; 42: 742 – 755.

Parkinson study Group., 2000. Pramiperxole Vs. levodopa as initial treatment for

Parkinson’s disease: a randomized controlled trial. IAMA; 284: 1931-1938.

Parrotta JA., 2001. Healing plants of Peninsular India Wellington, UK and New

York. CABI Publishing; P-917.

Patel DK, Amin KS, Nanavati DD., 1995. Celastrus paniculatus - A review. Ind

Drugs; 32: 556-73.

Perier C, Bovee J, Dehay B, Jackson-Lewis V, Rabinovitch PS, Przedborskivila

M., 2010. Apoptosis inducing factor deficiency sensitizes dopaminergic neurons

to Parkinsonian neurontoxins. Ann Neurol; 68(2): 184-92.

Perrisoud D and Testa B.,1982. Hepatic pharmacology Mechanisms of action and

classification of antinecrotic hepatoprotective agents. Trends Pharmacol Sci; 3:

365 369.

Petter A, Ward RS, Rao EV and Raju NR., 1981. 8-substituted flavonoids and 3-

substituted 7-oxygenated chalcones from Tephrosia purpurea. J Chem Soc; 2491.

Philippe H, Emmanuel B, Robert F, Stephane P, Robert D, Sussell TM and Flint

BM, 1996. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced

Parkinsonism in baboons. Nature Medicine; 2: 101-1021.

Bibliography


Pifl C, Giros B and Caron MG., 1993. Dopamine transporter expression confers

cytoxicity to low doses of the Parkinsonism-inducing neurotoxin 1-methyl-4-

phenylpyridinium. J Neurosci; 13: 4246-4253.

Pisa M., 1998. Regional specialization of motor function in the rat striatun,

implications for the treatment of parkinsonism, Prog. Neuro Pharmacol Biol

Psy;12: 217-24.

Pletscher A., 1973. Effect of inhibitors of extracerebral carboxylase on leveodopa

metabolism. Adv Neuro; 3: 49-58.

Plino D, Bruno A, Emmanuel PS., 2007. BMC structural Biology, 7,52-56.

Poonia BS, Sasmal D, and Mazumdar PM., 2006. Antidepressant activity of

methanol extract of Listea polyantha Bark. Indian Drugs; 43 (6): 467-470

Porsolt RD, Bertin A, Blavet N, Deniel M, Jalfree M., 1979. Immobility induced

by forced swimming in rats; effect of agents, which modify central catecholamine

and serotonin activity. Eur J Pharmacol; ST: 201-10.

Porsolt RD, Bertin A, Jalfre M., 1977. Behavioural despair in mice: A primary

screening test for antidepressants. Archives Internationales de pharmacodynamie

et de therapie; 229: 327-36.

Prashanth KV, Shashidhara S, Kumar MM and Sridhara BY., 2000. Effect of

Luffa echinata on lipid peroxidation and free scavenging activity. J Pharm

Phramacol; 52:891-894.

Przedborski S and Jackson-L., 1998. Mechanism of MPTP toxicity. Mov. Disord;

13(1): 35-38.

Rajaram M, Janardhan K., 1992. Nutritional and Chemical evaluation of raw

seeds of Canavalia gladiata. Plant foods Hum Nutr; 42 (4):329-336.

Bibliography


Rajendran V, Joseph T, David J., 1996. Reappraisal of dopaminergic aspects of

Mucuna pruriens and Comparative profile with L-dopa on cardiovascular and

CNS in animals. Indian drugs; 33(9): 465-472.

Rakotorina VS, Bum EM, Rakotonirena A, and Boplet M., 2001. Sedative

properties of the decoction of the rhizome of Cyperus anticulatives. Fitoterapia;

72: 22-29.

Rang HP, Dale MM, Ritter JM., 1991. Pharmacology churchill Livingstone, 4th

ed: 485-499.

Rao EV and Raju NR., 1979. Occurrence of (-)-Isolon chocarpin in the roots of

Tephrosia purpurea. Phytochem; 18: 1581-82.

Rao EV and Raju NR., 1984. Two flavonoids from Tephrosia purpurea.

Phytochem; 23: 2339-42.

Rascol O., 2000. A five year study of the incidence of dyskinesia in patients with

early Parkinsons disease who were treated with ropinirole (or) levodopa. 056

study group. N Engl J Med; 342: 1484-1491.

Ravindra GM, Shailaja M, Kalpana SP., 2003. Anthelmintic activity of Root bark

of Capparis zeylanica. Indian. J. Nat. Prod; 121(4): 50-51.

Ravishanker B, Bhaskaran Nair R, Sasikala CK., 1986. Pharmacology of Vitex

negundo root. Journal of Res Ayur Siddha; 7(1-2): 62-77.

Ray Gibanananda and Hussain Syed Akhtar., 2002. Oxidants, antioxidants and

carcinogenesis, Ind. J. Exp. Biol; 41:1288.

Riemersma RA, Carruthers KF, Elton RA and Fox KA., 2000. Vitamin C and the

risk of acute myocardial infarction. American J Clin Nutr; 179 (71): 1181-1186.

Robert SF, Jerrold SM, Linda FQ., 1987. Principles of Neuropsycho-

pharmacology, Sinauer Associates Inc., Publishers, Sunderland, 861-886.

Bibliography


Ross R., 1993. Pathogenesis of atherosclerosis a perspective for the 1990s,

Nature; 362:801-804.

Roy AE, Bakay, Massimo S, Fiandaca, Daniel L, Barrow, Arthur Schiff, Delwood

C, Collins., 1985. Preliminary report on the use of fetal tissue transplantation to

correct MPTP induced Parkinson like syndrome in primates. Appl Neurophysiol;

48: 358-361.

Sagarika E, Er TR, Jansz and Baboo M Nair., 1999. Proximate composition,

Mineral and amino acid content of mature seeds of Canavalia gladiata. Food

Chemistry; 66(1):115-119.

Sainani GS, Manika JS and Sainani RG., 1997. Oxidative stress: A key factor in

pathogenesis of chronic diseases. Med. Update; 1: 1-1.

Salahdeen HM, and Yemitan OK., 2006. Neuropharmacological effects of

aqueous leaf extract of Bryophyllum pinnatum in mice. Afr. J. Biomedical

Research ; 9 (2): 101-107.

Sanchez-Moreno C., 2002. Methods used to evaluate the free radical scavenging

activity in foods and biological systems. Food Sci. Tech. Int; 8:122-125.

Sang EK, Joo YC, Yearn SC, Yong C and Won YL., 2003. Serotonin Transporters in

the midbrain of Parkinson’s disease patients: A study with 123 I-B-CIT SPECT.

Journal of Nuclear Medicine; 44(6): 870-876.

Sankaranarayanan S, Bama P, Ramachandran S, Kalaichelvan PT, Deccaraman

M, Vijayalakshimi R, Dhamotharan B, Dananjeyan B, and Sathya Bama S., 2010.

Ethnobotanical study of medicinal plants used by traditional users in Villupuram

district of Tamil Nadu, India. J. Med. Plant. Res; 4(12): 1089-1101.

Saraf MA, El-Ansari and Nabiel AMS., 1997. Flavonoids of four cleome and

three capparis species. Biochemical Systematic Ecology. 25 (2): 161-166 (1997).

Sato Y, Kikuyama M, Oizumi K., 1997. High prevalence of Vitamin D deficiency

and reduced bone mass in Parkinson’s disease. Neurology; 49(5): 1273-1278.

Bibliography


Sauer J., 1964. Revision of canavalia. Brettonia; 16: 106-181

Schapira AH, Mann VM, cooper JM, Dexter D, Daniel SE, Jenner P, clark JB and

Marsden CD., 1990. Anatomic and disease specificity of NMDH COQ1 reductase

(complex-I) deficiency in Parkinson’s disease. J Neurochem; 55: 2142-2145.

Schultz W, Scarnati E, Sundstron E, Tsutsumi T and Jonsson G., 1986. The

catecholamine uptake blocker nomifensine protects against MPTP-induced

Parkinsonism in monkeys. Exp Brain Res;63: 216-220.

Schwartz J., 2003. Rationale for Dopamine agonist use as monotherapy in

Parkinson’s disease. Curr Pin Neurol; 16(1): S27-33.

Schwarz MJ, Houghton PJ, Rose S, Jenner P, Lees AD., 2003. Activities of

extract and constituents of Banisteriopsis caapi relevant to Parkinsonism

Pharmacol. Biochem Behav; 75(3): 627-33.

Selby G., 1990.Stable parkinsonian syndrome and uneven loss of striatal

dopamine fibres following chronic MPTP administration in baboons. Clinical

Features; 333-388.

Sengstock GW, Olanow CW, Dunn AJ and Arendash GW., 1992. Iron induces

degeneration of nigrostriatal neurons. Brain Res Bull; 28: 645-649.

Sengstock GW, Olanow CW, Menzies RA, Dunn AJ, and Arendash GW., 1993.

Infusion of iron into the rat Substania nigra: Nigral pathology and dose dependent

loss of dominergic markers. J Neurosci Res; 35: 67-82.

Shanti N and Dandiya PC., 1994. Glutathione as a cerebral substrate in depressive

behavior. Pharmacology Biochemistry and Behavior; 48(4): 845-851.

Sheng LX, Jin Z., 1998. Protective effects of Schisanhenol, Salvianolic acid A

and Sy-Zon oxidative stress induced injuries of cerebral cells and their

mechanisms. NCBI; 29(1): 35-8.

Bibliography


Sheth UK, Dhadkar NK and Usha GK., 1972. Selected topics in experimental

pharmacology; Ist ed, Kothari Book Depot, Bombay; pp.124.

Shirwaikar Annie and Somashekar AP., 2003. Antiinflammatory activity and free

radical scavenging studies of Aristolochia bracteolata Lam. Indian J Pharm Sci;

65:68-73.

Shore PA and Giachetti A., 1956. Reserpine: Basic and Clinical Pharmacology. In:

Iversen.L Iversen SD and Snyder SH (eds). Handbook of Psychopharmacology,

Vol.10, Plenumpress, New York. pp. 197-219.

Silva BA, Ferreres F, Malva J, Dias ACP., 2005. Phytochemical and antioxidant

characterization of Hypericum perforatum alcoholic extracts. Food Chem; 90:

157-67.

Silver K and Taptiklis ELR., 2005. Herbal Foods: Are they efficacious and Safe?

Nutrition Today; 40: 13-16.

Simpson BB, Solbrig OT., 1977. Introduction. Mesquite: its biology in two desert

ecosystems. (ed .B.B Simpson).Dowden, Hutchinson and Ross, Inc.,Stroudsberg,

PA: pp.1-25

Singh B, Chandan BK, Prabhakar A, Taneja SC, Singh J, Qazi GN., 2005.

Chemistry and heatoprotective activity of an active fraction from Barleria

priontis linn in experiment animals. Phytother Res; 18: 391-404.

Sreejayan N and Rao MNA., 1996. Free radical scavenging activity of

curcuminoids, Drug Res; 46:169.

Sreejayan N and Rao MNA., 1997): Nitric oxide scavenging by curcuminoids. J

Pharm Pharmacol; 49:105.

Staden JR, Kelly KM, and Bell WE., 1993. Antibacterial activity of seed of

Dichrostachys cinerea, Physiology and Molecular Biology of plants; 326-329.

Bibliography


Steller H., 1995. Mechanisms and genes of cellular suicide. Science; 267: 1445-

1449.

Stephen J, Kish PhD, Kathleen S, Shannak, Ali H, Rajput MD, Joseph, Gilbert

MD, Oleh Hornykiewicz MD., 1984. Cerebellar norepinephrine in patients with

Parkinson’s disease and control subject. Arch Neurol; 41(6): 612-614.

Stern MB., 1997. Contemporary therapy approaches to the pharma cotherapeutic

management of Parkinson’s disease. Neurology; 49 (1):32-9.

Steru L, Chermat R, Thierry B, Simon P., 1985. The tail suspension test: A new

method for screening antidepressants in mice. Psychopharmacol; 85: 367-70.

Stoof JC, Booij J and Drukarch B., 1992. Amantadine as N-methyl 1-D-aspartic

acid receptor antagonist: new possibilities for therapeutic applications? Clin

Neurol Neurosurg; 94: S4-S6.

Strupper A, Erbel F and Velh F., 1978. An overview on the pathophysiology of

Parkinsonian and other pathological tremors. Prog Clin Neurophysiol; 5: 114-128.

Sugihara N, Arakawa T, Ohnishi M and Furunko K., 1999. Anti and pro-oxidative

effects of flavavoids as meta-induced lipid hydroperoxide-dependent lipid

peroxidation in cultured hepatocytes loaded with alpha linoleic acid. Free Rad

Biol Med;27:1313-1323.

Sung SP, Toshihisa S, Hideki O, Osamu N and Makoto K., 2000.Complete amino

acid sequence of the proteinase inhibitors from white sword bean (Canavalia

gladiata). Biochem and Mole Biol ; 64(10): 2272-2275.

Suryawamshi CP, Patil VR, Chaudhari RY, Kale MK, Firake SD, Pimprikar RB,

Patil MD, Yeshwante SB and Saindanem DS., 2009. Antiparkinsonian effect of

Cassiatora on oxotremorine induced Parkinson methodology. Res J Pharmacol

and Pharmacodynamics; 1(1): 42-45.

Takei Y, Yamauchi D and Minamikawa T., 1989. Nucleotide sequence of the

Canavalia gladiata seeds. Nucl Acids Res.17 : 4381.

Bibliography


Tanner CM and Langston JW., 1990. Do environmental toxins cause Parkinson’s

disease? A critical review Neurology; 40(3): 17-30.

Tanner CM., 1989. The role of environmental toxins in the etiology of

Parkinson’s disease. Trends Neurosci; 12: 49-54.

Thatte U, Pandit SA and Shah LP., 1995. Ashwagandha (Withania Somnifera).

Arch Indi Psychiat; 2: 53-55.

Tillerson JL, Michael CW, Reverson ME, Miller GW., 2002. Detection of

behavioral impairment correlated to neurochemical deficits in mice treated with

moderate dose of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Exp Neurol;178:

80-90.

Tipton KF, Singer TP., 1993. Advances in our understanding of the mechanism

of neurotoxicity of MPTP and related compounds. J Neurochem; 6:1191-1206.

Triggs WJ and Will more LJ., 1984. In vivo lipidperoxidation in rat brain

following intracortical Fe2+

injection. J Neurochem; 42: 976-980.

Tsang D, Yeung HW, Tso WW, Peck H., 1985. Ginseng saponins influence on

neurotransmitter uptake in rat brian synaptosomes. Planta Med;3: 221-224.

Tyler VE., 1997. The Herbal Remedies market, Chemtech; 52-56.

Tyler VE., 1999. Invited Review, Phyto. J. Nat Prod ; 62 (11): 1589-1592.

Upaganlawar AB, Chopde VV, Ghule BV, Yeole PG., 2008. Analgesic effects

of methanolic extracts of Capparis zeylanica roots. Phcog Mag.; 4 (13): 90-

94.

Vaidya AB, Rajagopalan TG, Mankodi NA, Antarkar DS, Antarkar DS, Purohit

AV and Wadia NH., 1978. Treatment of Parkinson’s disease with the cowhage

plant-mucuna pruriens Bank Neurology (India); 28: 171-175.

Bibliography


Valentao P, Fernandes E, Carvalho F, Andrade PB, Seabra RM and Bastos ML.,

2002. Studies on the antioxidant activity of Lippa citriodoru infusion scavenging

effect on superoxide radicals, hydroxyl radical and hypochlorous acid. Biol

Pharm Bull; 25: 1324-1327.

Van Kampen J, Robertson H, Hagg T, Drobitch R., 2003. Neuroprotective actions

of the ginseng extract G115 in two rodent models of Parkinson’s disease. Exp

Neurol; 184 (1): 521-529.

VanKampen JM, Mcgeer EG, Stoessl AJ., 2000. Dopamine transporter function

assessed by antisense knock down in the rat. Protection from dopamine

neurotoxicity. Synapse; 37: 171-178.

Virinder SP, Jatendra SR, Rajini J, Deirdre A, Hendersona and John FM., 1989.

Occurrence of pongamol as the enol structure in Tephrosia purpurea. Phytochem;

28: 591-593.

Walker R, Edwards C (2003). Clin Pharm and Ther ; 3: 483-493.

Wallace DC., 1992. Mitochondrial genetics: a paradigm of aging and generative

disease? Sci Mag ; 256(5057): 628-632.

Watt JM and Breyer- Brandwijk MG., 1962. The medicinal and poisonous plants

of southern and eastern Africa, 2nd

ed. Ex S. Livingstone, Ltd, Edinburgh and

London.;pp199-201.

Wichmann T and Delong MR., 1993. Pathophysiology of parkinsonian motor

abnormalities. Adv Neurol; 60: 53-61.

Wilkinson IA., 1998. The potential of Herbal products for Neutraceutical and

Pharmaceutical development, IBC, 5th

Annual conference, London, 784-789.

Xiao YL, Fu JM, Dong Z, Yang JA, Zeng FX, Zhu LX, He BC., 2004.

Neuroprotective mechanism of modafinilon on Parkinson’s disease induced by 1-

methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Acta Pharmacol Sin; 25(3): 301-

305.

Bibliography


Yaadov S, Richard MD, Lucien CMD., 1984. Reaction time and vigilance in

Parkinsons possible role of altered norepinephrine metabolism. Archives of

Neurology; 41(10): No.10.

Yang SF, Wu Q, Sun AS, Huang XN, Shi JS., 2001. Protective effect and

Mechanism of Ginkgo biloba leaf extract for Parkinson’s disease induced by 1-

methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Acta Pharmacol Sin; 22(12): 1089-

1093.

Yokiko T, Daisuke Y and Jakao MK., 1989. Nucleotide sequence of the canavalin

gene from Canavalia gladiata seeds. Nucleic Acid Research; 17(11): 4380-4381.

Yoshikawa T, Tanaka H, Yoshida H, Sato O, Sugino N and Kondo M.,

1983. Adjuvant arthritis and lipidperoxidation protection by superoxide

dismutase, Lipid peroxide. Res; 7: 108-112.

Youdim MBH., 1990. Neuropharmacological and Neurobiological aspects of iron

deficiency. In: Brian, Behaviour and Iron in the infant Diet. Springer-Verlag ; 83-

97.

Youdim KA and Joseph JA., 2001. A possible emerging role of Phytochemicals

in improving age-related neurological dysfunctions a multiplicity of effects. Free

Rad Biol; 30: 583.

Yuksel A, Cengiz M, Seven M, Ulutin T., 2001. Changes in the Antioxidant

system and Hepatic enzymes in epileptic children receiving antiepileptic drugs

two years prospective studies. J Chil Neurol ; 16: 603-606.

Zhang ZT, Cao XB, Xiong N, Wang HC, Huang JS, Sun SG, Wang T., 2010.

Morin exerts neuroprotective action in Parkinson disease models invitro and

invivo. Acta Pharmacol Sin; 31(8): 900-906.

Zhao CL, Guo HC, Dong ZY, Zhao Q., 2009. Pharmacological and nutritional

activities of potato anthocyanins. Afr. J. Pharm and Pharmacol; 3(10): 463-468.

Bibliography


Zhao G, Zheng XW, Qin GW, Gai Y, Jiang ZH and Guo LH., 2009. Invitro

dopaminergic neuroprotective and invivo antiparkinsonian like effects of Δ3, 2-

hydroxybackuchiol isolated from Psoralea corylifolia (2). Cell and Mole. Life

Sci.; 66(9): 1617-1627.

Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Striker EM., 1990.

Compensation after lesions of central dopaminergic neurons some clinical and

basic implications. Trends Neurosci; 13: 290-96.

Zolfaghari R and Harden M., 1982. Nutritional value of Mesquite beans (Prosopis

glandulosa). In: Pareker HW (ed.) Mesquite utilization. Texas Tech university,

Lubbock, USA, K1-K6.

Date post:	07-Aug-2020
Category:	Documents
Upload:	others
View:	3 times
Download:	0 times

SPMVV, Tirupati. - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/6744/12/12...Eduardo HSB,...

Documents